Advancing breakthrough therapies for patients with serious diseases that have no/limited options. Founder & CEO of biotherapeutics company PureTech (NASDAQ/LSE: PRTC). 27 new therapeutics initiated by our team, 16 in clinical testing and 2 cleared for marketing by FDA and other regulatory agencies
Pronouns: She/her
Invited by: Ethan Perlstein
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
June 18, 2024 | 2,594 | -1 | -0.1% |
May 15, 2024 | 2,595 | -2 | -0.1% |
February 17, 2024 | 2,597 | -1 | -0.1% |
January 30, 2024 | 2,598 | -1 | -0.1% |
January 13, 2024 | 2,599 | -1 | -0.1% |
December 28, 2023 | 2,600 | +1 | +0.1% |
November 14, 2023 | 2,599 | -1 | -0.1% |
October 26, 2023 | 2,600 | -1 | -0.1% |
October 18, 2023 | 2,601 | -1 | -0.1% |
October 09, 2023 | 2,602 | -1 | -0.1% |